Reck M, Granados ALO, de Marinis F, Meyers O, et al. Patient-reported outcomes in patients with metastatic non-squamous non-small cell lung cancer from the randomized Phase II PERLA trial comparing first-line chemotherapy plus dostarlimab or pembrolizumab. Eur J Cancer 2024;212:115050.
PMID: 39378565